AIMS: The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man. METHODS: On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography. RESULTS: Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of < or = 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of > or = 16 pmol min(-1). CONCLUSIONS: Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.
AIMS: The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man. METHODS: On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography. RESULTS:Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of < or = 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of > or = 16 pmol min(-1). CONCLUSIONS: Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.
Authors: D E Newby; F N Witherow; R A Wright; P Bloomfield; C A Ludlam; N A Boon; K A A Fox; D J Webb Journal: Heart Date: 2002-01 Impact factor: 5.994
Authors: D E Newby; D G Sciberras; C J Ferro; B J Gertz; D Sommerville; A Majumdar; R C Lowry; D J Webb Journal: Br J Clin Pharmacol Date: 1999-09 Impact factor: 4.335
Authors: Fiona E Strachan; David E Newby; David G Sciberras; Jacqueline B McCrea; Michael R Goldberg; David J Webb Journal: Br J Clin Pharmacol Date: 2002-10 Impact factor: 4.335
Authors: Christian M Pedersen; Sowmya Venkatasubramanian; Henrik Vase; Janus A Hyldebrandt; Hussain Contractor; Michael R Schmidt; Hans Erik Bøtker; Nicholas L Cruden; David E Newby; Rajesh K Kharbanda; Ninian N Lang Journal: Br J Clin Pharmacol Date: 2016-03-10 Impact factor: 4.335
Authors: Christian M Pedersen; Gareth Barnes; Michael R Schmidt; Hans Erik Bøtker; Rajesh K Kharbanda; David E Newby; Nicholas L Cruden Journal: Eur Heart J Date: 2011-10-11 Impact factor: 29.983
Authors: Sowmya Venkatasubramanian; Megan E Griffiths; Steven G McLean; Mark R Miller; Rosa Luo; Ninian N Lang; David E Newby Journal: J Am Heart Assoc Date: 2013-01-31 Impact factor: 5.501